HGH Fragment 176-191
5 mg
Growth Hormone Fragment
HGH Fragment 176-191
C-terminal fragment of hGH for lipolysis-specific research.
Prices in AUD. Tax included.
Research Use Only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.
Description
HGH Fragment 176-191 is the C-terminal fragment of human growth hormone, encompassing amino acids 176-191. Unlike AOD-9604, this is the unmodified natural fragment. Research focuses on its lipolytic activity independent of the growth-promoting and diabetogenic effects of full-length hGH.
Specifications
- SKU
- HGHF-5MG
- Size
- 5 mg
- Form
- Lyophilised Powder
- Purity
- >99%
- Storage
- -20°C (lyophilised), 2-8°C (reconstituted)
- Shipping
- Australia Post — 3–5 business days
Research Summary
Studies indicate HGH Frag 176-191 stimulates lipolysis approximately 12.5 times more potently than full-length hGH in adipose tissue assays. It does not compete for the GH receptor and does not affect IGF-1 or insulin levels. Research suggests its mechanism involves beta-3 adrenergic receptor interaction and hormone-sensitive lipase activation.
Testing Protocol
- HPLC Purity Analysis
- Mass Spectrometry Identity Verification
- Endotoxin Screening (LAL Test)